[63] Survodutide, Mazdutide, Pemvidutide, MariTide, Ecnoglutide, and Bimagrumab Other emerging therapies include dual GLP-1/glucagon receptor agonists such as survodutide, mazdutide, and pemvidutide, long-acting antibody-based or peptide-conjugate approaches such as maridebart cafraglutide (MariTide), biased GLP-1 receptor agonists such as ecnoglutide, and body-composition-targeted therapies such as bimagrumab, which targets activin type II receptors to reduce fat mass while preserving or increasing lean mass
The Ozempic BoomAnd What Were Missing Ozempic (semaglutide) is a GLP-1 receptor agonist that mimics a hormone your gut already produces after meals
Its best to treat this supplement as a complement to stress-relieving practices, such as exercise, meditation, talking with trusted friends and family, as this is not a magic pill
Follow-ups track progress and determine how long treatment should continue